$3.77
arrow_drop_down1.30%Key Stats | |
---|---|
Open | $3.98 |
Prev. Close | $3.82 |
EPS | -5.37 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $7.73M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 3.63 | 4.02 |
52 Week Range | 0.45 | 6.40 |
Ratios | |
---|---|
EPS | -5.37 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
NeuroMetrix Reiterates its Review of Strategic Alternatives
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call
NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024
NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)